compare
Argus HQ vs FDA Tracker (Leucine)
They're free and comprehensive. We're paid and curated. Here's the honest tradeoff.
30-day money-back guarantee. No forms. No sales call. Cancel in one click — refunded fast.
FDA Tracker, built by Leucine, is a free, AI-powered searchable archive of FDA enforcement records — warning letters, Form 483 observations, import alerts, recalls, and guidances — going back to 2012, with over 148,000 records and new actions parsed within minutes of publication. It's a genuinely strong, no-cost resource, and we want to say that plainly before getting into where Argus HQ is actually different.
The honest version of this comparison isn't "we're better." It's that FDA Tracker and Argus HQ solve adjacent but distinct problems for a compliance team, and which one you need depends on whether you want a searchable archive or a daily, curated brief.
| Argus HQ — $199/mo | FDA Tracker (Leucine) | |
|---|---|---|
| Cost | $199/mo ($1,990/yr) | Free, sign up with a work email |
| Archive depth | Focused on Warning Letters, matched to your watchlist | 148,000+ records since 2012 across warning letters, 483s, import alerts, recalls, guidances |
| Delivery method | Curated daily email brief, 6am ET, watchlist-matched | Searchable dashboard — you go find it |
| Watchlist matching to specific companies/competitors | Yes — daily brief filtered to your named watchlist | Full-text and filtered search, not a standing personalized daily brief |
| Setup time | Under 15 minutes, watchlist wizard | Instant account creation, no watchlist curation step |
| Update speed | Same-day, matched against your watchlist | New actions parsed within minutes of FDA publication |
| Persona focus | Compliance officer's morning ritual, Bloomberg-shape brief | General-purpose regulatory intelligence search tool |
What FDA Tracker genuinely does well
148,000+ records, free, updated within minutes of FDA publication, spanning warning letters, 483s, import alerts, recalls, and guidances — that is a serious, useful archive, and the price (zero, no credit card) makes it accessible to any compliance team regardless of budget. If your job is periodic deep research across the full breadth of FDA enforcement activity, FDA Tracker's searchable archive is a strong, free starting point.
We're not going to pretend a $199/mo product beats a free one on raw feature breadth. It doesn't, and anyone telling you otherwise isn't being straight with you.
What Argus HQ does differently: the daily ritual, not the archive
Argus HQ isn't trying to be a comprehensive searchable database. It's built around a specific, narrower job: reading every FDA Warning Letter the day it publishes, matching it against your specific watchlist of named competitors, CDMOs, and therapeutic areas, and landing a short, readable brief in your inbox at 6am ET — before your standup, with no login required. That's a fundamentally different product shape than a search tool you have to remember to check.
The difference matters most for the specific failure mode compliance officers actually worry about: not "I couldn't find the data," but "I found out about a competitor's warning letter from someone else in a meeting, because I didn't think to search for it that week." A curated push brief, matched to a standing watchlist, is built specifically to close that gap; a search archive, however comprehensive, still requires you to remember to look.
The honest tradeoff
If your team wants a comprehensive, free, searchable archive and has the discipline (or a dedicated analyst) to check it regularly, FDA Tracker is a strong, no-cost choice, and there's no reason to pay us instead. If your team wants a specific, narrower job done automatically — a daily, watchlist-matched brief that requires no one to remember to check anything — that's the job Argus HQ is built for, and it's worth the $199/mo to a compliance officer whose time is the actual constraint, not access to data.
Some teams reasonably use both: FDA Tracker for deep, ad hoc research across the full archive, and Argus HQ for the standing daily habit of not missing something relevant to a specific watchlist. They're not mutually exclusive, and we don't think you should feel bad about using the free tool alongside us.
Why we don't try to out-feature a free product
We could try to build a bigger searchable archive to compete head-on with FDA Tracker's 148,000 records, but we think that would be the wrong bet: it's genuinely hard to beat a well-built free product on raw archive breadth, and trying to would distract from the specific job — the reliable, curated morning brief — we think is actually underserved in this market. Instead we've focused entirely on making the daily brief itself as good, as relevant, and as low-friction as possible for a specific compliance persona.
Frequently asked questions
Is FDA Tracker really free, with no catch?
Based on Leucine's published information, yes — sign up with a work email, no credit card, no trial clock, full search access to the archive.
Does Argus HQ have a searchable archive like FDA Tracker's?
Argus HQ is built around the daily watchlist-matched brief rather than a general-purpose searchable archive; if broad ad hoc search across the full FDA enforcement history is your primary need, FDA Tracker's free archive may suit you better.
Can I use both tools together?
Yes, and many compliance teams reasonably do — FDA Tracker for deep research, Argus HQ for the standing daily habit of a curated, watchlist-matched brief.
Why would anyone pay $199/mo when a comparable free tool exists?
Because the two products solve different jobs: a free searchable archive still requires someone to remember to search it, while a paid curated brief is delivered automatically, matched to your specific watchlist, without anyone having to remember to check anything.
Questions about a specific comparison? signals@argushq.ai